Francesca Spyrakis (F Spyrakis)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 53

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

ACS chemical neuroscience

Pharmaceuticals (Basel, Switzerland)

University of Turin

University of Parma (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Turin Oct 01 2006

Italy

Associate Professor :: Drug Science and Technology

Education History

University of Parma

Italy

PHD :: Departmant of Biochemistry and Molecular Biology

Publications

G A Tiburtini, L Bertarini, M Bersani, T A Dragani, B Rolando, A Binello, A Barge, Francesca Spyrakis
In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body. Archives of toxicology 98 (9) (2024)
Alan Santini, Elisa Tassinari, Eleonora Poeta, Manuela Loi, Elisabetta Ciani, Stefania Trazzi, Rebecca Piccarducci, Simona Daniele, Claudia Martini, Barbara Pagliarani, Andrea Tarozzi, Matteo Bersani, Francesca Spyrakis, Daniela Danková, Christian A Olsen, Roberto Soldati, Vincenzo Tumiatti, Serena Montanari, Angela De Simone, Andrea Milelli
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's Disease. ACS chemical neuroscience 15 (11) (2024)
G A Tiburtini, L Bertarini, M Bersani, T A Dragani, B Rolando, A Binello, A Barge, Francesca Spyrakis
In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body. Archives of toxicology 98 (9) (2024)
G A Tiburtini, L Bertarini, M Bersani, T A Dragani, B Rolando, A Binello, A Barge, Francesca Spyrakis
In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body. Archives of toxicology 98 (9) (2024)
Greta Bajetto, Davide Arnodo, Matteo Biolatti, Linda Trifirò, Camilla Albano, Selina Pasquero, Francesca Gugliesi, Eva Campo, Francesca Spyrakis, Cristina Prandi, Marco De Andrea, Valentina Dell'Oste, Ivan Visentin, Marco Blangetti
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum . Microorganisms 12 (2) (2024)
Greta Bajetto, Davide Arnodo, Matteo Biolatti, Linda Trifirò, Camilla Albano, Selina Pasquero, Francesca Gugliesi, Eva Campo, Francesca Spyrakis, Cristina Prandi, Marco De Andrea, Valentina Dell'Oste, Ivan Visentin, Marco Blangetti
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum . Microorganisms 12 (2) (2024)
G A Tiburtini, L Bertarini, M Bersani, T A Dragani, B Rolando, A Binello, A Barge, Francesca Spyrakis
In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body. Archives of toxicology (2024)
Alan Santini, Elisa Tassinari, Eleonora Poeta, Manuela Loi, Elisabetta Ciani, Stefania Trazzi, Rebecca Piccarducci, Simona Daniele, Claudia Martini, Barbara Pagliarani, Andrea Tarozzi, Matteo Bersani, Francesca Spyrakis, Daniela Danková, Christian A Olsen, Roberto Soldati, Vincenzo Tumiatti, Serena Montanari, Angela De Simone, Andrea Milelli
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's Disease. ACS chemical neuroscience (2024)
Alan Santini, Elisa Tassinari, Eleonora Poeta, Manuela Loi, Elisabetta Ciani, Stefania Trazzi, Rebecca Piccarducci, Simona Daniele, Claudia Martini, Barbara Pagliarani, Andrea Tarozzi, Matteo Bersani, Francesca Spyrakis, Daniela Danková, Christian A Olsen, Roberto Soldati, Vincenzo Tumiatti, Serena Montanari, Angela De Simone, Andrea Milelli
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's Disease. ACS chemical neuroscience 15 (11) (2024)
Alan Santini, Elisa Tassinari, Eleonora Poeta, Manuela Loi, Elisabetta Ciani, Stefania Trazzi, Rebecca Piccarducci, Simona Daniele, Claudia Martini, Barbara Pagliarani, Andrea Tarozzi, Matteo Bersani, Francesca Spyrakis, Daniela Danková, Christian A Olsen, Roberto Soldati, Vincenzo Tumiatti, Serena Montanari, Angela De Simone, Andrea Milelli
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's Disease. ACS chemical neuroscience 15 (11) (2024)
Francesca Spyrakis, Tommaso Antonio Dragani
The EU's Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science. Toxics 11 (9) (2023)
Matteo Bersani, Mariacristina Failla, Filippo Vascon, Eleonora Gianquinto, Laura Bertarini, Massimo Baroni, Gabriele Cruciani, Federica Verdirosa, Filomena Sannio, Jean Denis Docquier, Laura Cendron, Francesca Spyrakis, Loretta Lazzarato, Donatella Tondi
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco Mazzorana, Maria Paola Costi, Michele Tonelli
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective. Journal of medicinal chemistry 66 (6) (2023)
Melissa Guardigni, Letizia Pruccoli, Alan Santini, Angela De Simone, Matteo Bersani, Francesca Spyrakis, Flavia Frabetti, Elisa Uliassi, Vincenza Andrisano, Barbara Pagliarani, Paula Fernández-Gómez, Valle Palomo, Maria Laura Bolognesi, Andrea Tarozzi, Andrea Milelli
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer's Disease. ACS chemical neuroscience (2023)
Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco Mazzorana, Maria Paola Costi, Michele Tonelli
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective. Journal of medicinal chemistry (2023)
Matteo Bersani, Mariacristina Failla, Filippo Vascon, Eleonora Gianquinto, Laura Bertarini, Massimo Baroni, Gabriele Cruciani, Federica Verdirosa, Filomena Sannio, Jean Denis Docquier, Laura Cendron, Francesca Spyrakis, Loretta Lazzarato, Donatella Tondi
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco Mazzorana, Maria Paola Costi, Michele Tonelli
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective. Journal of medicinal chemistry 66 (6) (2023)
Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco Mazzorana, Maria Paola Costi, Michele Tonelli
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective. Journal of medicinal chemistry (2023)
Sarmistha Majumdar, Francesco Di Palma, Francesca Spyrakis, Sergio Decherchi, Andrea Cavalli
Molecular Dynamics and Machine Learning Give Insights on the Flexibility-Activity Relationships in Tyrosine Kinome. Journal of chemical information and modeling (2023)
Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco Mazzorana, Maria Paola Costi, Michele Tonelli
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective. Journal of medicinal chemistry (2023)
Matteo Biolatti, Marco Blangetti, Melissa Baggieri, Antonella Marchi, Silvia Gioacchini, Greta Bajetto, Davide Arnodo, Paola Bucci, Raoul Fioravanti, Maedeh Kojouri, Matteo Bersani, Giulia D'Arrigo, Lydia Siragusa, Simone Ghinato, Marco De Andrea, Francesca Gugliesi, Camilla Albano, Selina Pasquero, Ivan Visentin, Emilio D'Ugo, Francesca Esposito, Paolo Malune, Enzo Tramontano, Cristina Prandi, Francesca Spyrakis, Fabio Magurano, Valentina Dell'Oste
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease M pro . ACS infectious diseases (2023)
Giulia D'Arrigo, Ida Autiero, Eleonora Gianquinto, Lydia Siragusa, Massimo Baroni, Gabriele Cruciani, Francesca Spyrakis
Exploring Ligand Binding Domain Dynamics in the NRs Superfamily. International journal of molecular sciences 23 (15) (2022)
Omar De Bei, Marialaura Marchetti, Luca Ronda, Eleonora Gianquinto, Loretta Lazzarato, Dimitri Y Chirgadze, Steven W Hardwick, Lee R Cooper, Francesca Spyrakis, Ben F Luisi, Barbara Campanini, Stefano Bettati
Cryo-EM structures of staphylococcal IsdB bound to human hemoglobin reveal the process of heme extraction. Proceedings of the National Academy of Sciences of the United States of America 119 (14) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Valentina Fiorilli, Marco Forgia, Alexandre de Saint Germain, Giulia D'Arrigo, David Cornu, Philippe Le Bris, Salim Al-Babili, Francesca Cardinale, Cristina Prandi, Francesca Spyrakis, François-Didier Boyer, Massimo Turina, Luisa Lanfranco
A structural homologue of the plant receptor D14 mediates responses to strigolactones in the fungal phytopathogen Cryphonectria parasitica. The New phytologist 234 (3) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Elias Dahdouh, Lisa Allander, Linda Falgenhauer, Bogdan I Iorga, Stefano Lorenzetti, Íñigo Marcos-Alcalde, Nathaniel I Martin, Luis Martínez-Martínez, Jesús Mingorance, Thierry Naas, Joseph E Rubin, Francesca Spyrakis, Thomas Tängdén, Paulino Gómez-Puertas
Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network. International journal of molecular sciences 23 (17) (2022)
Giulia D'Arrigo, Eleonora Gianquinto, Sybille Krauß, Gabriele Cruciani, Stefano Lorenzetti, Francesca Spyrakis
Binding of Androgen- and Estrogen-Like Flavonoids to Their Cognate (Non)Nuclear Receptors: A Comparison by Computational Prediction. Molecules (Basel, Switzerland) 26 (6) (2021)
Valentina Dell'Oste, Francesca Spyrakis, Cristina Prandi
Strigolactones, from Plants to Human Health: Achievements and Challenges. Molecules (Basel, Switzerland) 26 (15) (2021)
Matteo Santucci, Rosaria Luciani, Eleonora Gianquinto, Cecilia Pozzi, Flavio di Pisa, Lucia Dello Iacono, Giacomo Landi, Lorenzo Tagliazucchi, Stefano Mangani, Francesca Spyrakis, Maria Paola Costi
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Aurore Fraix, Cristina Parisi, Mariacristina Failla, Konstantin Chegaev, Francesca Spyrakis, Loretta Lazzarato, Roberta Fruttero, Alberto Gasco, Salvatore Sortino
NO release regulated by doxorubicin as the green light-harvesting antenna. Chemical communications (Cambridge, England) 56 (47) (2021)
Gaetano Marverti, Chiara Marraccini, Andrea Martello, Domenico D'Arca, Salvatore Pacifico, Remo Guerrini, Francesca Spyrakis, Gaia Gozzi, Angela Lauriola, Matteo Santucci, Giuseppe Cannazza, Lorenzo Tagliazucchi, Addolorata Stefania Cazzato, Lorena Losi, Stefania Ferrari, Glauco Ponterini, Maria Paola Costi
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting. Journal of medicinal chemistry 64 (6) (2021)
Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, Christina F Sandall, Marta Giorgis, Elisabetta Marini, Federica Blua, Margherita Gallicchio, Francesca Spyrakis, Justin A MacDonald, Massimo Bertinaria
Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor. Molecules (Basel, Switzerland) 26 (13) (2021)
Jonas Goßen, Simone Albani, Anton Hanke, Benjamin P Joseph, Cathrine Bergh, Maria Kuzikov, Elisa Costanzi, Candida Manelfi, Paola Storici, Philip Gribbon, Andrea R Beccari, Carmine Talarico, Francesca Spyrakis, Erik Lindahl, Andrea Zaliani, Paolo Carloni, Rebecca C Wade, Francesco Musiani, Daria B Kokh, Sybille Krauß
A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics. ACS pharmacology & translational science 4 (3) (2021)
Pasquale Linciano, Eleonora Gianquinto, Martina Montanari, Lorenzo Maso, Pierangelo Bellio, Esmeralda Cebrián-Sastre, Giuseppe Celenza, Jesús Blázquez, Laura Cendron, Francesca Spyrakis, Donatella Tondi
4-Amino-1,2,4-triazole-3-thione as a Promising Scaffold for the Inhibition of Serine and Metallo-β-Lactamases. Pharmaceuticals (Basel, Switzerland) 13 (3) (2020)
Luca Ronda, Alessandro Tonelli, Elisa Sogne, Ida Autiero, Francesca Spyrakis, Sara Pellegrino, Giorgio Abbiati, Elisa Maffioli, Carsten Schulte, Riccardo Piano, Pietro Cozzini, Andrea Mozzarelli, Stefano Bettati, Francesca Clerici, Paolo Milani, Cristina Lenardi, Gabriella Tedeschi, Maria Luisa Gelmi
Rational Design of a User-Friendly Aptamer/Peptide-Based Device for the Detection of Staphylococcus aureus. Sensors (Basel, Switzerland) 20 (17) (2020)
Eleonora Gianquinto, Donatella Tondi, Giulia D'Arrigo, Loretta Lazzarato, Francesca Spyrakis
Can We Exploit β-Lactamases Intrinsic Dynamics for Designing More Effective Inhibitors? Antibiotics (Basel, Switzerland) 9 (11) (2020)
Marialaura Marchetti, Omar De Bei, Stefano Bettati, Barbara Campanini, Sandra Kovachka, Eleonora Gianquinto, Francesca Spyrakis, Luca Ronda
Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development. International journal of molecular sciences 21 (6) (2020)
Matteo Biolatti, Marco Blangetti, Giulia D'Arrigo, Francesca Spyrakis, Paola Cappello, Camilla Albano, Paolo Ravanini, Santo Landolfo, Marco De Andrea, Cristina Prandi, Valentina Dell'Oste
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. Microorganisms 8 (5) (2020)
Carolina Estarellas, Salvatore Scaffidi, Giorgio Saladino, Francesca Spyrakis, Lorella Franzoni, Carles Galdeano, Axel Bidon-Chanal, Francesco Luigi Gervasio, Francisco Javier Luque
Modulating Ligand Dissociation through Methyl Isomerism in Accessory Sites: Binding of Retinol to Cellular Carriers. The journal of physical chemistry letters 10 (23) (2019)
Eleonora Gianquinto, Ilaria Moscetti, Omar De Bei, Barbara Campanini, Marialaura Marchetti, F Javier Luque, Salvatore Cannistraro, Luca Ronda, Anna Rita Bizzarri, Francesca Spyrakis, Stefano Bettati
Interaction of human hemoglobin and semi-hemoglobins with the Staphylococcus aureus hemophore IsdB: a kinetic and mechanistic insight. Scientific reports 9 (1) (2019)
Francesca Spyrakis, Pierangelo Bellio, Antonio Quotadamo, Pasquale Linciano, Paolo Benedetti, Giulia D'Arrigo, Massimo Baroni, Laura Cendron, Giuseppe Celenza, Donatella Tondi
First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase. Journal of computer-aided molecular design 33 (2) (2019)
Federica Sodano, Loretta Lazzarato, Barbara Rolando, Francesca Spyrakis, Carmen De Caro, Salvatore Magliocca, Domenica Marabello, Konstantin Chegaev, Elena Gazzano, Chiara Riganti, Antonio Calignano, Roberto Russo, Maria Grazia Rimoli
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug. Molecular pharmaceutics 16 (10) (2019)
Federica Sodano, Barbara Rolando, Francesca Spyrakis, Mariacristina Failla, Loretta Lazzarato, Elena Gazzano, Chiara Riganti, Roberta Fruttero, Alberto Gasco, Salvatore Sortino
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor. ChemMedChem 13 (12) (2018)
Pasquale Linciano, Laura Cendron, Eleonora Gianquinto, Francesca Spyrakis, Donatella Tondi
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design. ACS infectious diseases 5 (1) (2018)
Gabriele Cruciani, Nicoló Milani, Paolo Benedetti, Susan Lepri, Lucia Cesarini, Massimo Baroni, Francesca Spyrakis, Sara Tortorella, Edoardo Mosconi, Laura Goracci
From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions. Journal of medicinal chemistry 61 (1) (2017)
Lydia Siragusa, Rosaria Luciani, Chiara Borsari, Stefania Ferrari, Maria Paola Costi, Gabriele Cruciani, Francesca Spyrakis
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case. ChemMedChem 11 (15) (2016)

Francesca Spyrakis.css-eqlu8i{font-size:small;padding-left:4px;} (F Spyrakis)

Publication Activity (10 Years)

Top Topics

Top Venues

Francesca Spyrakis (F Spyrakis)